| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 1.3K | 1.1% | 14.8% |
| Total Income | 1.3K | 1.4% | 14.1% |
| Expenditure | 1.2K | 1.2% | 17.3% |
| PBT | 80.19 | 9.8% | 19.9% |
| Net Profit | 62.43 | 5.9% | 17.7% |
| OPM | 9.25% | 1.17pp | 1.84pp |
| NPM | 4.75% | 0.33pp | 1.83pp |
| EPS | 17.60 | 5.8% | 17.8% |
Galaxy Surfactants Q4 FY26: Revenue ₹1,315 Cr, PAT ₹62.4 Cr
14 May 2026 · 14 May, 9:02 pm
Summary
Galaxy Surfactants Limited reported consolidated revenue of ₹1,315.0 crore for Q4FY26, an increase of 14.1% year-on-year, and ₹5,270.4 crore for the full fiscal year, up 24.0% year-on-year. Despite robust revenue growth, profit after tax (PAT) for Q4FY26 declined by 17.7% to ₹62.4 crore, and full-year PAT decreased by 12.3% to ₹267.4 crore. The managing director, Mr. K. Natarajan, highlighted resilient performance amid a disrupted operating environment caused by the West Asia conflict, which impacted global supply chains and input costs. The company managed to support its performance through effective cost pass-throughs, an improved specialty product mix, and disciplined cost control. Management expressed confidence in navigating challenges via agile pricing actions and continued focus on specialty growth, anticipating sequential improvement in the coming quarters.
Key Highlights
- 1
Galaxy Surfactants Limited reported Q4FY26 total revenue of ₹1,315.0 crore, marking a 14.1% increase year-on-year.
- 2
The company's total revenue for the full fiscal year FY26 grew by 24.0% year-on-year, reaching ₹5,270.4 crore.
- 3
Profit after tax (PAT) for Q4FY26 stood at ₹62.4 crore, reflecting a 17.7% decrease compared to the prior year period.
- 4
For the full year FY26, PAT declined by 12.3% year-on-year to ₹267.4 crore.
- 5
Q4FY26 EBITDA was recorded at ₹121.9 crore, a 9.5% decrease year-on-year, with EBITDA/MT at ₹20,113 compared to ₹21,715 in Q4FY25.
- 6
India region demonstrated resilience, achieving high single-digit volume growth year-on-year in Q4, primarily driven by strong traction in Specialty Care Products.
- 7
The AMET region experienced a mid-teens year-on-year decline in volumes during Q4, attributed to logistics disruptions, raw material constraints, and geopolitical uncertainty.
Management Comments
K. Natarajan
Our performance in Q4 and full year FY26 remained resilient despite a highly disrupted operating environment amid the ongoing West Asia conflict, which impacted global supply chains, logistics, and input costs. EBITDA for Q4FY26 stood at ₹122 crore compared to ₹135 crore in Q4FY25, with EBITDA/MT at ₹ 20,113 versus ₹21,715 in the corresponding period last year, supported by effective pass-through of cost increases, an improved specialty product mix, strong performance of premium segments, and disciplined cost control. India remained resilient with volumes growing by high single-digit on YoY in Q4, led by strong traction in Specialty Care Products and steady demand across Performance and non-Tier 1 segments, which helped offset earlier reformulation headwinds. The AMET region witnessed a mid-teens YoY decline in volumes, primarily in the latter part of the quarter, due to logistics disruptions, raw material constraints, and cautious ordering by customers amid geopolitical uncertainty. The Rest of the World recorded mixed trends, with volumes declining by high single digit YoY in Q4 due to shipment delays and elevated freight costs, while maintaining a 4% growth for the full-year. The Americas emerged as a relatively bright spot with sequential improvement in demand following tariff reversals and renewed traction in specialty products. Further, while supply-side disruptions posed near-term challenges, the Company remains confident of navigating the environment through agile pricing actions, strong customer partnerships, continued focus on specialty growth, and expects sequential improvement in the coming quarters supported by a resilient business model and diversified global footprint.
Informational and educational content only. Not investment advice.